Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Abroad (travel likely)RecruitingPHASE1

Conditions

Hodgkin Disease · CD30-Positive Diffuse Large B-Cell Lymphoma · CD30+ Anaplastic Large Cell Lymphoma · CD30+ Pleomorphic Large T-Cell Cutaneous Lymphoma · CD30+ Immunoblastic Large T-Cell Cutaneous Lymphoma · Leukemia · Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Guru Subramanian Guru Murthy, MD, MS) · gmurthy@mcw.edu · 414-805-4600
    Contact: Principal Investigator (Guru Subramanian Guru Murthy, MD, MS)
Study leads
  • Guru Subramanian Guru Murthy, MD, MS

    Principal Investigator

    Medical College of Wisconsin